Literature DB >> 29428232

Evaluating the Effect of Margin Consensus Guideline Publication on Operative Patterns and Financial Impact of Breast Cancer Operation.

Neal Bhutiani1, Megan K Mercer1, Katelynn C Bachman1, Samantha R Heidrich1, Robert C G Martin1, Charles R Scoggins1, Kelly M McMasters1, Nicolás Ajkay2.   

Abstract

BACKGROUND: This study sought to evaluate re-excision rates, patient satisfaction with their breasts, and healthcare costs before and after publication of 2014 Society of Surgical Oncology/American Society of Radiation Oncology consensus guideline on margins for breast conserving operation with whole-breast irradiation for stage I and II breast cancer at an academic institution. STUDY
DESIGN: Patients with stage I and II invasive carcinomas who underwent partial mastectomy were divided into 2 groups based on whether they were treated before (PRE) or after (POST) guideline publication in March 2014. Groups were compared with respect to re-excision rates, conversion to mastectomy, specimen volumes, mean cost per patient of surgical care, and prospectively collected patient post-procedure quality of life.
RESULTS: A total of 237 patients who underwent partial mastectomy were examined (n = 126 in the PRE group and n = 111 in the POST group). Patients in the POST group were less likely to require re-excision (9% POST vs 37% PRE; p < 0.001) and were less likely to undergo conversion to mastectomy (5% POST vs 14% PRE; p = 0.02). After consensus guideline publication, mean operative cost per patient decreased ($4,874 POST vs $5,772 PRE; p < 0.001), and patients had improved breast quality of life scores (77 out of 100 POST vs 61 out of 100 PRE; p = 0.03). On multivariable analysis, publication of the consensus statement was an independent predictor of decreased re-excision rates (odds ratio 0.17; 95% CI 0.08 to 0.38; p < 0.001) and operative cost per patient (odds ratio 0.14; 95% CI 0.78 to 0.30; p < 0.001).
CONCLUSIONS: Widespread implementation of the consensus guideline on margins for breast conserving operation will likely lead to the intended improvements in operative and financial outcomes, as well as patient satisfaction with breast conserving operation.
Copyright © 2018 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29428232     DOI: 10.1016/j.jamcollsurg.2018.01.050

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  9 in total

Review 1.  Update of the American Society of Breast Surgeons Toolbox to address the lumpectomy reoperation epidemic.

Authors:  Maureen P McEvoy; Jeffrey Landercasper; Himani R Naik; Sheldon Feldman
Journal:  Gland Surg       Date:  2018-12

2.  Was Reexcision Less Frequent for Patients with Lobular Breast Cancer After Publication of the SSO-ASTRO Margin Guidelines?

Authors:  Anita Mamtani; Emily C Zabor; Laura H Rosenberger; Michelle Stempel; Mary L Gemignani; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2019-08-27       Impact factor: 5.344

3.  Barriers and Facilitators to De-Implementation of the Choosing Wisely® Guidelines for Low-Value Breast Cancer Surgery.

Authors:  Margaret E Smith; C Ann Vitous; Tasha M Hughes; Sarah P Shubeck; Reshma Jagsi; Lesly A Dossett
Journal:  Ann Surg Oncol       Date:  2020-03-02       Impact factor: 5.344

4.  A Statewide Approach to Reducing Re-excision Rates for Women With Breast-conserving Surgery.

Authors:  Jessica R Schumacher; Elise H Lawson; Amanda L Kong; Joseph J Weber; Jeanette May; Jeffrey Landercasper; Bret Hanlon; Nicholas Marka; Manasa Venkatesh; Randi S Cartmill; Sudha Pavuluri Quamme; Connor Nikolay; Caprice C Greenberg
Journal:  Ann Surg       Date:  2022-07-15       Impact factor: 13.787

5.  Adoption of SSO-ASTRO Margin Guidelines for Ductal Carcinoma in Situ: What Is the Impact on Use of Additional Surgery?

Authors:  Anita Mamtani; Anya Romanoff; Raymond Baser; Alain Vincent; Monica Morrow; Mary L Gemignani
Journal:  Ann Surg Oncol       Date:  2020-06-04       Impact factor: 5.344

6.  Does Surgical Margin Width Remain a Challenge for Triple-Negative Breast Cancer? A Retrospective Analysis.

Authors:  Eduard-Alexandru Bonci; Ștefan Țîțu; Alexandru Marius Petrușan; Claudiu Hossu; Vlad Alexandru Gâta; Morvarid Talaeian Ghomi; Paul Milan Kubelac; Teodora Irina Bonci; Andra Piciu; Maria Cosnarovici; Liviu Hîțu; Alexandra Timea Kirsch-Mangu; Diana Cristina Pop; Ioan Cosmin Lisencu; Patriciu Achimaș-Cadariu; Doina Piciu; Hank Schmidt; Bogdan Fetica
Journal:  Medicina (Kaunas)       Date:  2021-02-26       Impact factor: 2.430

7.  De-escalation in breast cancer surgery.

Authors:  Sarah P Shubeck; Monica Morrow; Lesly A Dossett
Journal:  NPJ Breast Cancer       Date:  2022-02-23

8.  Margin Width and Local Recurrence in Patients Undergoing Breast Conservation After Neoadjuvant Chemotherapy.

Authors:  Mary Mrdutt; Alexandra Heerdt; Varadan Sevilimedu; Anita Mamtani; Andrea Barrio; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2021-07-30       Impact factor: 4.339

9.  Reoperation rate after breast conserving surgery as quality indicator in breast cancer treatment: A reappraisal.

Authors:  Francesca Tamburelli; Furio Maggiorotto; Caterina Marchiò; Davide Balmativola; Alessandra Magistris; Franziska Kubatzki; Paola Sgandurra; Maria Rosaria Di Virgilio; Daniele Regge; Filippo Montemurro; Marco Gatti; Anna Sapino; Riccardo Ponzone
Journal:  Breast       Date:  2020-08-13       Impact factor: 4.380

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.